Oncotelic Therapeutics, Inc. Presents PLA Framework and mTOR Signature at 22nd Drug Discovery Strategic Summit

Oncotelic Therapeutics said Chief Business Officer Saran Saund presented at the 22nd Drug Discovery Strategic Summit in Millbrae, California, on October 22, 2026. The article text is truncated after the presentation title begins, so it provides no further details about the presentation or its implications.